Senseonics targets $68M-$70M 2026 revenue as Freedom CGM human testing begins (NASDAQ:SENS)


Earnings Call Insights: Senseonics (SENS) Q3 2026

Management View

  • “Q3 was a breakout quarter for Senseonics.” (President, CEO & Director Tim Goodnow) “Revenue reached $19.6 million, up about 140%, well more than double the prior year.” (President, CEO & Director Goodnow) “Our sales are running ahead of our earlier expectations, and we are now

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.



Source link

“Spoken to Marvel”- Karen Gillan Gets Candid About a Possible MCU Return

Joseph Owusu Identified As New York Man Found In Duffel Bag

Leave a Reply

Your email address will not be published. Required fields are marked *